Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children
- PMID: 21852764
- PMCID: PMC3158859
- DOI: 10.1097/INF.0b013e3182186035
Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children
Abstract
Linezolid administration has been associated with lactic acidosis in adults; however, the same phenomenon has not been reported in children. Mitochondrial protein synthesis inhibition is a demonstrated mechanism for toxicity, which therefore may manifest as lactic acidosis. Three cases of linezolid-associated lactic acidosis in children are reported to reinforce the need for pediatric caregivers to be vigilant of this potential side effect.
References
-
- Apodaca A, Rakita R. Linezolid-induced lactic acidosis. N Engl J Med. 2003;348(1):86–87. - PubMed
-
- Palenzuela L, Hahn N, Nelson R, Jr, et al. Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis? Clin Infect Dis. 2005;40:e113–116. - PubMed
-
- Pea F, Scudeller L, Lugano M, et al. Hyperlactatemia potentially due to linezolid overexposure in a liver transplant patient recipient. Clin Infect Dis. 2006;42:434–435. - PubMed
-
- De Vriese A, Van Coster R, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis. 2006;42:1111–1117. - PubMed
-
- Soriano A, Miro O, Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med. 2005;353(21):2305–2306. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical